Dana-Farber Cancer Institute: Immunotherapy Post-Surgery Improves Overall Survival for Kidney Cancer
April 18, 2024
April 18, 2024
BOSTON, Massachusetts, April 18 -- The Dana-Farber Cancer Institute issued the following news release on April 17, 2024:
* * *
*This press release was initially issued on January 27, 2024. It has been updated and re-issued to reflect publication in the New England Journal of Medicine.
* * *
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant ther . . .
* * *
*This press release was initially issued on January 27, 2024. It has been updated and re-issued to reflect publication in the New England Journal of Medicine.
* * *
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant ther . . .